Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance.
Xiaowei LiuFengli ZuoJinen SongLeyi TangXueyan WangXinyu LiuHao ZhangZhankun YangJing JingXuelei MaHubing ShiPublished in: Cell discovery (2024)